Curis About
Curis: Curis, Inc. is a therapeutic drug development
company. The Company’s technology focus is on regulatory pathways that control
repair and regeneration. Curis’ product development involves the use of proteins
or small molecules to modulate these pathways. Curis has successfully used this
technology and product development approach to produce several promising drug
product candidates in the fields of cancer (under partnership with Genentech,
which also includes a co-development collaboration between Curis and Genentech
for a basal cell carcinoma product candidate), kidney disease (licensed to Ortho
Biotech, a subsidiary of Johnson & Johnson), neurological disorders (partnered
with Wyeth Pharmaceuticals), hair growth, and cardiovascular disease. Hh
topical small molecule antagonist Basal cell carcinoma Hh systemic small
molecule or antibody antagonist Cancer BMP-7 protein Kidney disease Hh
small molecule agonist Nervous system disorders Hh small molecule agonist
Hair growth Hh agonist/protein/gene Cardiovascular disease
More on Curis"